BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37790939)

  • 1. Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis.
    Wang X; Richard ML; Caldwell TS; Sundararaj K; Sato S; Nowling TK; Zhang XK
    Front Immunol; 2023; 14():1219279. PubMed ID: 37790939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.
    Sundararaj KP; Thiyagarajan T; Molano I; Basher F; Powers TW; Drake RR; Nowling TK
    J Immunol; 2015 Dec; 195(12):5551-60. PubMed ID: 26538397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.
    Sato S; Zhang XK
    Clin Exp Immunol; 2014 Jul; 177(1):102-9. PubMed ID: 24580413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
    Sato S; Zhang XK; Matsuoka N; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Temmoku J; Fujita Y; Asano T; Migita K
    Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37094946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fli-1 transcription factor regulates the expression of CCL5/RANTES.
    Lennard Richard ML; Sato S; Suzuki E; Williams S; Nowling TK; Zhang XK
    J Immunol; 2014 Sep; 193(6):2661-8. PubMed ID: 25098295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis.
    Sato S; Zhang XK; Temmoku J; Fujita Y; Matsuoka N; Yashiro-Furuya M; Asano T; Kobayashi H; Watanabe H; Migita K
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression.
    Sato S; Lennard Richard M; Brandon D; Jones Buie JN; Oates JC; Gilkeson GS; Zhang XK
    Arthritis Rheumatol; 2014 Dec; 66(12):3436-44. PubMed ID: 25155007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice.
    Zhang XK; Gallant S; Molano I; Moussa OM; Ruiz P; Spyropoulos DD; Watson DK; Gilkeson G
    J Immunol; 2004 Nov; 173(10):6481-9. PubMed ID: 15528390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.
    Campanella GS; Colvin RA; Luster AD
    PLoS One; 2010 Sep; 5(9):e12700. PubMed ID: 20856926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice.
    Molano I; Mathenia J; Ruiz P; Gilkeson GS; Zhang XK
    Clin Exp Immunol; 2010 May; 160(2):275-82. PubMed ID: 20015093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCL10/CXCR3 Axis Promotes Disease Pathogenesis in Mice upon CVA2 Infection.
    Liang R; Chen S; Jin Y; Tao L; Ji W; Zhu P; Li D; Zhang Y; Zhang W; Duan G
    Microbiol Spectr; 2022 Jun; 10(3):e0230721. PubMed ID: 35604176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases.
    Gao J; Wu L; Wang S; Chen X
    Mediators Inflamm; 2020; 2020():6194864. PubMed ID: 32089645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation.
    Lennard Richard ML; Nowling TK; Brandon D; Watson DK; Zhang XK
    Mol Immunol; 2015 Feb; 63(2):566-73. PubMed ID: 25108845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice.
    Mathenia J; Reyes-Cortes E; Williams S; Molano I; Ruiz P; Watson DK; Gilkeson GS; Zhang XK
    Clin Exp Immunol; 2010 Nov; 162(2):362-71. PubMed ID: 20731671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
    Menke J; Zeller GC; Kikawada E; Means TK; Huang XR; Lan HY; Lu B; Farber J; Luster AD; Kelley VR
    J Am Soc Nephrol; 2008 Jun; 19(6):1177-89. PubMed ID: 18337479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
    Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.
    Suzuki E; Karam E; Williams S; Watson DK; Gilkeson G; Zhang XK
    Clin Immunol; 2012 Dec; 145(3):201-8. PubMed ID: 23108091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Fas
    Lee JH; Lee HK; Kim HS; Kim JS; Ji AY; Lee JS; Kim KS; Lee TY; Bae SC; Kim Y; Hong JT; Han SB
    Lupus; 2018 Oct; 27(11):1854-1859. PubMed ID: 30139297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.